Lisa Christopher-Stine MD, MPHAssociate Professor, Director, Johns Hopkins Myositis Center: Division of Rheumatology: Department of Medicine; Johns Hopkins University School of Medicine, Baltimore, MD
Lisa Christopher-Stine, MD, MPH is an Associate Professor of Medicine and Neurology and the Co-Founder and Director of the Johns Hopkins Myositis Center. She joined the faculty of the Division of Rheumatology at The Johns Hopkins University in 2003. In addition, she serves as the Co-Chair of the Institutional Review Board at the Johns Hopkins University Bayview Campus. She is one of 24 core faculty members to teach in the Johns Hopkins Medical School Colleges Advisory Program which provides clinical skills instruction in the first year of medical school and continued career advising throughout all four years of medical school. As a clinician- scientist, she is the Principal Investigator of the Johns Hopkins Myositis Registry, currently numbering well over 2000 patients recruited worldwide, developed by her and her colleagues. She has a strong interest in patient-reported outcomes and has been the co-chair of an international effort through the OMERACT (Outcome measures in Rheumatology) organization to develop a novel myositis patient reported outcome measure. She has published over 110 peer reviewed scientific papers. She also currently serves as the Deputy Director of Telemedicine in the Division of Rheumatology.
Education and training:
Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College where she was elected to the Phi Beta Kappa Honor Society. She was elected to the Alpha Omega Alpha medical honor society at Hahnemann University School of Medicine, where she received her MD degree. She attained her Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training in Internal Medicine were completed at MCP Hahnemann University, where she also served as Chief Resident, after which she pursued rheumatology fellowship training at Johns Hopkins.
COI: L.C-S. has research support from Pfizer, Corbus and Kezar and has served on advisory boards for UCB (not Myositis related), Janssen, Boehringer-Ingelheim, Mallinckrodt, Serono, Argenx, Roivant and Dysimmune Disease Foundation (DDF) and received compensation for consultancy work from Guidepoint and Allogene. She is also a patent holder on an assay for anti-HMGCR autoantibodies for which she received royalty payments from Inova Diagnostics.